Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine carboxypeptidase 1 (SCPEP1)
- Target
- SCPEP1
- Molecular classification
- Enzyme, Serine protease, Serine carboxypeptidase
01
Overview
Serine carboxypeptidase 1 (SCPEP1) is a serine-type carboxypeptidase enzyme encoded by the SCPEP1 gene in humans[4]. It is predicted to enable hydrolysis of terminal peptide bonds from the carboxy end of proteins, involving a serine in its active site. SCPEP1 is also known as a retinoid-inducible enzyme, and it is involved in processes such as negative regulation of blood pressure and retinoic acid metabolism[4]. Its broader molecular family is that of serine carboxypeptidases, which act as proteolytic enzymes. No specific approved drugs are currently described to target SCPEP1 directly, and its clinical biomarker or safety profile is not established in the search results. It has been considered relevant in cardiovascular biology, particularly relating to blood pressure regulation[4].
- Other names
- Retinoid-inducible serine carboxypeptidaseRISCSCP1MSTP034UNQ265/PRO302HSCP1serine carboxypeptidase 1 precursor protein
02
Mechanism of action
Serine-type carboxypeptidase activity (hydrolysis of terminal carboxy-terminal peptide bonds via active-site serine)
03
Biological functions
Protein and peptide degradationMetabolism of retinoic acidRegulation of blood pressure
04
Disease associations
Cardiovascular diseaseOther
Beyond the preview
Go deeper on Serine carboxypeptidase 1 (SCPEP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Serine carboxypeptidase 1 (SCPEP1).